Axonis Therapeutics
UEI: LR1MVZHCSJ95
• CAGE: 8EMJ2
Overview
Awardee Type
Parent
Company Description
AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
Name
Axonis Therapeutics
Website
Headquarters
Boston, MA
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
AXONIS THERAPEUTICS, INC.
(UEI LR1MVZHCSJ95, CAGE 8EMJ2)
is headquartered in Boston MA.
The corporation
was founded in March 2010 and
federally registered in
October 2019.
Federal Award Analysis
Axonis Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AXONIS THERAPEUTICS, INC.
UEI
LR1MVZHCSJ95
CAGE Code
8EMJ2
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
March 25, 2010
Initial Registration
Oct. 10, 2019
Last Registration
July 15, 2024
Registration Activation
July 12, 2024
Registration Expiration
July 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No
People
Vendor contacts at Axonis Therapeutics
Grant Awards
Axonis Therapeutics direct grants
Subgrant Awards
Axonis Therapeutics subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Axonis Therapeutics